Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Programmed Intermittent Bolus vs Continuous Perfusion Epidural
NCT02705872Phase 2Withdrawn
- Sponsor
- CHU Brugmann
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of levobupivacaine and sufentanil in labor pain, sponsored by CHU Brugmann. Primary endpoints: Rate of instrumented deliveries (suction pumps, forceps) and Rate of cesarian sections. Planned start Mar 2016; status: withdrawn.
02
Drugs
levobupivacainesufentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT02705872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02705872.